Connection

Gili Regev-Yochay to Humans

Back to Details
This is a "connection" page, showing publications Gili Regev-Yochay has written about Humans.
Gili Regev-Yochay
Connection Strength
0.112
Humans
  1. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 10 14; 385(16):1474-1484.
    View in: PubMed
    Score: 0.008
  2. Postvaccination COVID-19 among Healthcare Workers, Israel. Emerg Infect Dis. 2021 04; 27(4):1220-1222.
    View in: PubMed
    Score: 0.007
  3. Absence of in-flight transmission of SARS-CoV-2 likely due to use of face masks on board. J Travel Med. 2020 12 23; 27(8).
    View in: PubMed
    Score: 0.007
  4. The Sheba Medical Center healthcare workers' children's school: can we open schools safely? Clin Microbiol Infect. 2021 Mar; 27(3):474.e1-474.e3.
    View in: PubMed
    Score: 0.007
  5. Characteristics of Clinically Asymptomatic Patients with SARS-CoV-2 Infections, Case Series. Prehosp Disaster Med. 2021 Feb; 36(1):125-128.
    View in: PubMed
    Score: 0.007
  6. [THE EFFECT OF PNEUMOCOCCAL CONJUGATE VACCINE ON PNEUMOCOCCAL CARRIAGE AND INVASIVE DISEASE]. Harefuah. 2019 May; 158(5):316-320.
    View in: PubMed
    Score: 0.007
  7. Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR). PLoS One. 2018; 13(11):e0206927.
    View in: PubMed
    Score: 0.006
  8. Sink traps as the source of transmission of OXA-48-producing Serratia marcescens in an intensive care unit. Infect Control Hosp Epidemiol. 2018 11; 39(11):1307-1315.
    View in: PubMed
    Score: 0.006
  9. Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel. Hum Vaccin Immunother. 2018; 14(10):2527-2532.
    View in: PubMed
    Score: 0.006
  10. Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009-June 20151. Emerg Infect Dis. 2018 07; 24(7):1275-1284.
    View in: PubMed
    Score: 0.006
  11. Staphylococcus aureus Colonization Induces Strain-Specific Suppression of Interleukin-17. Infect Immun. 2018 03; 86(3).
    View in: PubMed
    Score: 0.006
  12. Clinical evaluation of early acquisition of Staphylococcus aureus carriage by newborns. Int J Infect Dis. 2017 Nov; 64:9-14.
    View in: PubMed
    Score: 0.006
  13. The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel. Vaccine. 2017 04 25; 35(18):2449-2456.
    View in: PubMed
    Score: 0.006
  14. Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus? J Antimicrob Chemother. 2011 Oct; 66(10):2199-214.
    View in: PubMed
    Score: 0.004
  15. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine. Am J Obstet Gynecol. 2021 11; 225(5):577-579.
    View in: PubMed
    Score: 0.002
  16. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. JAMA Netw Open. 2021 08 02; 4(8):e2122255.
    View in: PubMed
    Score: 0.002
  17. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021 09; 9(9):999-1009.
    View in: PubMed
    Score: 0.002
  18. Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel. Euro Surveill. 2021 07; 26(26).
    View in: PubMed
    Score: 0.002
  19. SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses. Epidemiol Infect. 2021 06 24; 149:e153.
    View in: PubMed
    Score: 0.002
  20. COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply. Lancet. 2021 06 12; 397(10291):2249-2250.
    View in: PubMed
    Score: 0.002
  21. Establishing a COVID-19 treatment centre in Israel at the initial stage of the outbreak: challenges, responses and lessons learned. Emerg Med J. 2021 May; 38(5):373-378.
    View in: PubMed
    Score: 0.002
  22. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021 03 06; 397(10277):875-877.
    View in: PubMed
    Score: 0.002
  23. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis. PLoS One. 2020; 15(11):e0241164.
    View in: PubMed
    Score: 0.002
  24. Emergency Department Triage in the Era of COVID-19: The Sheba Medical Center Experience. Isr Med Assoc J. 2020 Aug; 22(8):470-475.
    View in: PubMed
    Score: 0.002
  25. Hospital-onset adult invasive pneumococcal disease in Israel: Sicker patients, different pathogens. Int J Infect Dis. 2019 Aug; 85:195-202.
    View in: PubMed
    Score: 0.002
  26. Genomic epidemiology of meticillin-resistant Staphylococcus aureus ST22 widespread in communities of the Gaza Strip, 2009. Euro Surveill. 2018 08; 23(34).
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.